Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Upstream Bio, Inc. - Common Stock
(NQ:
UPB
)
29.35
-0.51 (-1.71%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Upstream Bio, Inc. - Common Stock
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 02, 2025
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Tuesday?
↗
September 02, 2025
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial Finds
↗
September 02, 2025
Upstream Bio's Phase 2 trial of verekitug in chronic rhinosinusitis met all endpoints, showing reduced nasal polyps, congestion, and need for surgery.
Via
Benzinga
Upstream Bio (UPB) Q2 R&D Soars 169%
↗
August 06, 2025
Via
The Motley Fool
Alerus Financial Posts Better-Than-Expected Earnings, Joins Celcuity, SES AI, Abercrombie & Fitch And Other Big Stocks Moving Higher On Monday
↗
July 28, 2025
Via
Benzinga
Topics
Artificial Intelligence
Upstream Bio Stock Gets A Boost As New Lung Inflammation Drug Shows Higher Potency
↗
June 15, 2025
The company is progressing with multiple Phase 2 trials for its investigational treatment targeting severe respiratory diseases.
Via
Stocktwits
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 28, 2025
Via
Benzinga
Amtech Systems, Tesla And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
April 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 10, 2025
Via
Benzinga
Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket
↗
April 10, 2025
Via
Benzinga
Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 12, 2025
From
Upstream Bio
Via
GlobeNewswire
Discover the 3 Best-Performing Biotech IPO Stocks of 2024
November 06, 2024
Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.
Via
MarketBeat
Topics
Initial Public Offering
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
↗
November 05, 2024
Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics market.
Via
Benzinga
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
November 05, 2024
Via
Benzinga
Another Trio Of Biotech IPOs Made Friday Debut
↗
October 13, 2024
The Partners Group-backed KinderCare sold 24 million shares for $24 each this past Tuesday. Meanwhile, a new trio of biotech companies' shares came to market on Friday, as Upstream Bio, CeriBell, and...
Via
Talk Markets
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
